Clinical Trials Sponsored by Gencare Incorporated

Total 1279 results

Insmed Incorporated

Completed

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

Non-Cystic Fibrosis Bronchiectasis

United States, Spain, Korea, Republic of, Australia, Denmark, United Kingdom, Italy, Belgium, Singapore, Bulgaria, Germany, Netherlands, New Zealand, Poland
Insmed Incorporated

Completed

A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants

Healthy Volunteers

United States
Celularity Incorporated

Active, not recruiting

CYNK-101 in Combination With Trastuzumab and Pembrolizumab in Patients With Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

Metastatic HER2 Positive Gastroesophageal Junction Cancer

United States
GlycoMimetics Incorporated

Terminated

Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

Sickle Cell Disease | Sickle Cell Anemia | Vaso-occlusive Crisis | Pain Crisis | Sickle Cell Disorders

United States, Canada
VertiFlex, Incorporated

Completed

The STEPS - Totalis™ Trial

Lumbar Spinal Stenosis

United States
Celularity Incorporated

Completed

A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)

Multiple Myeloma

United States
GlycoMimetics Incorporated

Completed

A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.

Healthy

United States
GlycoMimetics Incorporated

Completed

Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease

Sickle Cell Disease

United States
VertiFlex, Incorporated

Withdrawn

Assessing Superion Clinical Endpoints vs. Decompression (ASCEND)

Spinal Stenosis, Lumbar Region With Neurogenic Claudication

United States
GlycoMimetics Incorporated

Completed

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Leukemia, Myeloid, Acute

United States, Ireland, Australia
Hollister Incorporated

Completed

The Advocate Study

Ostomy

United States, Canada
Celularity Incorporated

Completed

A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease

Crohns Disease

United States
Celularity Incorporated

Terminated

Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis

Stage 2 Pulmonary Sarcoidosis | Stage 3 Pulmonary Sarcoidosis

United States
Hollister Incorporated

Completed

Wound Fluid Protease Levels During Use of Novel Wound Dressing

Venous Stasis Ulcers

United States
Ingredion Incorporated

Completed

Effects of Dietary Fiber on Gastrointestinal Function

Gastrointestinal Health

United States
Ingredion Incorporated

Completed

Effects of a Dietary Fiber on Fecal Microbiota and Metabolism

Focus of the Study is on Gut Health

United States
Proacta, Incorporated

Terminated

Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

United States, Taiwan, Singapore, Hong Kong
Cebix Incorporated

Completed

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

Diabetes Mellitus | Type 1 Diabetes | Peripheral Diabetic Neuropathy

United States
Proacta, Incorporated

Terminated

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Lung Cancer

United States
Proacta, Incorporated

Unknown

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia

United States
Genta Incorporated

Unknown

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

Breast Neoplasm

United States
Genta Incorporated

Unknown

Study of Tesetaxel in Japanese Patients With Solid Tumors

Advanced Solid Tumors

Japan
Genta Incorporated

Completed

Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function

Normal Renal Function | Mildly Impaired Renal Function | Moderately Impaired Renal Function

United States
Hollister Incorporated

Completed

Preliminary Evaluation of CASTLE Barrier North American Prototype

Peristomal Skin Complication

United States, Canada
Genta Incorporated

Unknown

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Melanoma

United States
Genta Incorporated

Completed

Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Genta Incorporated

Completed

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma (AGENDA)

Melanoma

United States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
LensAR Incorporated

Unknown

Laser Treatment of the Crystalline Lens

Cataract

Mexico
LensAR Incorporated

Unknown

Prospective Clinical Trial of the LensAR Laser System

Cataract

Mexico
Genta Incorporated

Withdrawn

This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)

Lymphocytic Leukemia
Genta Incorporated

Completed

A Phase I Study of G3139 Subcutaneous in Solid Tumors

Tumors

United States
Cook Research Incorporated

Recruiting

European Aortic Data Collection Project (EADC)

Thoracoabdominal Aortic Aneurysm | Aortic Arch Aneurysm | Complex Abdominal Aortic Aneurysm | Chronic Aortic Dissection

Denmark, United Kingdom, France, Germany, Italy, Sweden
Cook Research Incorporated

Active, not recruiting

Zenith® p-Branch® Endovascular Graft Pivotal Study

Aortic Aneurysm Abdominal

United States
Cook Research Incorporated

Completed

Flourish™ Pediatric Esophageal Atresia

Digestive System Abnormalities | Esophageal Atresia | Esophageal Disorders Congenital

United States, Canada
Cook Research Incorporated

Completed

Zenith® Low Profile AAA Endovascular Graft

Abdominal Aortic Aneurysms | Iliac Aneurysms | Aortoiliac Aneurysms

United States, Canada
Cook Research Incorporated

Completed

Cook IVC Filter Study (CIVC)

Pulmonary Embolism

United States, Australia, United Kingdom
Cook Research Incorporated

Completed

TX2® Low Profile TAA Endovascular Graft (TX2® LP)

Aortic Aneurysm | Vascular Disease | Penetrating Ulcer

United States, Japan, Germany, Italy, Sweden, United Kingdom
Cook Research Incorporated

Completed

Zenith Alpha™ Abdominal Endovascular Graft

Aorto-iliac Aneurysm | Abdominal Aortic

Canada
Cook Research Incorporated

Completed

Zenith® p-Branch® OTS Multicenter Study

Aortic Aneurysm, Abdominal

United States
Cook Research Incorporated

Completed

TRANSFIX Zenith® Transection Clinical Study (TRANSFIX)

Thoracic Injuries | Thoracic Aorta | Blunt Injuries

United States
Cook Research Incorporated

Completed

Transvenous Lead Removal Post-Market Clinical Study

Cardiac Electrophysiology

United States, Netherlands, Germany, United Kingdom
Insmed Incorporated

Completed

A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

Pulmonary Hypertension

Belgium, Germany, Spain, Argentina, Australia, Italy, United Kingdom
Lenstec Incorporated

Completed

Clinical Evaluation of the Lenstec Softec HP1 Intraocular Lens

Aphakia

United Kingdom
Insmed Incorporated

Completed

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Cystic Fibrosis
Insmed Incorporated

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants

Healthy Volunteers

United States
Insmed Incorporated

Completed

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Healthy Volunteers
Celularity Incorporated

Active, not recruiting

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Cardiovascular Diseases | Vascular Diseases | Neoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Immunoproliferative Disorders | Hematologic Diseases | Hemorrhagic Disorders | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Antineoplastic Agents | Physiological... and other conditions

United States
Celularity Incorporated

Withdrawn

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type (CYNK001GBM02)

Glioblastoma | Glioblastoma Multiforme | Giant Cell Glioblastoma | Astrocytoma, Grade IV

United States
Celularity Incorporated

Completed

A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy

Peripheral Nervous System Diseases | Diabetic Nephropathies

United States
Insmed Incorporated

Completed

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia

Clinical Trials Sponsored by Gencare Incorporated

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations